A detailed history of Resonant Capital Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 370 shares of REGN stock, worth $259,684. This represents 0.03% of its overall portfolio holdings.

Number of Shares
370
Previous 348 6.32%
Holding current value
$259,684
Previous $365,000 6.3%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1024.09 - $1201.76 $22,529 - $26,438
22 Added 6.32%
370 $388,000
Q2 2024

Aug 01, 2024

BUY
$883.2 - $1071.19 $14,131 - $17,139
16 Added 4.82%
348 $365,000
Q1 2024

May 01, 2024

BUY
$902.69 - $993.35 $299,693 - $329,792
332 New
332 $319,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Resonant Capital Advisors, LLC Portfolio

Follow Resonant Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.